Market Chatter: Eli Lilly Plans to Launch Investigational Weight Loss Drug Orforglipron in India

Published 1 month ago Neutral
Market Chatter: Eli Lilly Plans to Launch Investigational Weight Loss Drug Orforglipron in India
Auto

Related Stocks

LILY34.SA Eli Lilly and C... LLY.BE Eli Lilly and C... LLY.MU Eli Lilly and C... LLY.MX Eli Lilly and C...
Eli Lilly (LLY) plans to introduce its experimental weight loss pill orforglipron in India, Reuters

PREMIUM

Upgrade to read this MT Newswires article and get so much more.

A Silver or Gold subscription plan is required to access premium news articles.

Upgrade

Already have a subscription? Sign in

More News

Anmodning om ophør af suspension i enkelt afdeling under Investeringsforeningen Danske Invest

35 minutes ago Neutral

Why James Hardie Industries (ASX:JHX) Is Down 18.9% After Surge in Class Action Lawsuits and Sales Disclosure

58 minutes ago Neutral

Transaction in Own Shares

1 hour ago Neutral

Digital Wallet Users to Surpass Three Quarters of Global Population by 2030

1 hour ago Neutral

Halper AI Launches to Transform the Future of SMEs From Digital Souls to Business Growth

1 hour ago Neutral